BackAbeona Therapeutics Overview
Abeona Therapeutics Inc

Abeona Therapeutics Target Price

See Abeona Therapeutics's analyst price targets ($18) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.22

Average Target Price

$17.67319.1% upside

3 analysts in the last 4 months

High: $21 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-17Roth Capital$17303.3% upsideOpen
2026-08-14Industrial Alliance Securities$15255.9% upsideOpen
2026-08-14OppenheimerJeff Jones$21398.2% upsideOpen
2026-03-17Stifel NicolausStephen Willey$17303.3% upsideOpen
2025-05-16Stifel NicolausStephen Willey$20374.5% upsideOpen
2025-03-05Oppenheimer$16279.6% upsideOpen
2022-11-14Leerink Partners$642.3% upsideOpen

Abeona Therapeutics (ABEO) FAQ

As of the most recent data, ABEO shows a target price of $18. Scroll down for historical charts and peer comparison views.

If Abeona Therapeutics moved to the average analyst target of $18, shares would be roughly 319.1% higher than $4.22. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Abeona Therapeutics's earnings trajectory.

Besides this target price page, Stockcircle has Abeona Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $18) with ownership activity and broader fundamentals.

Abeona Therapeutics's target price is $18; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.